Shubhada Bopegamage

Prof. Shubhada Bopegamage

Institute of Laboratory Medicine, Slovak Medical University, Bratislava, Bratislavský, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in Virology
Verified
Journal Article
Closed access
KDKristen M. Drescher
Kristen M. Drescher
KKKen Kono
Ken Kono
SBShubhada Bopegamage
Shubhada Bopegamage
SCSteven D. Carson
Steven D. Carson
STSteven Tracy
Steven Tracy

1 July 2015 in Folia Microbiologica
Verified
Journal Article
Open access
PDF file
MBMaria Borsanyiova
Maria Borsanyiova
APAmrita Patil
Amrita Patil
RMRuchira Mukherji
Ruchira Mukherji
APAsmita Prabhune
Asmita Prabhune
SBShubhada Bopegamage
Shubhada Bopegamage
Sophorolipids are surface active glycolipids consisting of a hydrophilic sophorose unit and a hydrophobic portion composed of a fatty acid tail. Crude sophorolipid sample contains both acidic and lactonic forms of sophorolipid with different degrees of acetylation and varying lengths of the fatty acid chains depending on the substrates used in the production process. Carboxylic end in the acidic form of the fatty acid is free, whereas in the lactonic form, it is internally esterified. Sophorolipids show different physicochemical properties with wide range of applications for each structural compound. Lactonic form of sophorolipids shows surface tension reducing ability and biological activity, whereas the acidic form possesses better foam forming ability and higher solubility. Presence of acetyl groups gives hydrophilic nature to the sophorolipids which promotes its antiviral and cytokine-stimulating properties. The aim of this review is to explore and suggest the plausibility of sophorolipids as therapeutic and prophylactic agents for the treatment of viral diseases.

1 December 2005 in Journal of General Virology
Verified
Journal Article
Closed access
PDF file
SBShubhada Bopegamage
Shubhada Bopegamage
JKJana Kovacova
Jana Kovacova
AVAgnesa Vargova
Agnesa Vargova
JMJana Motusova
Jana Motusova
APAnna Petrovicova
Anna Petrovicova
JGJochem M. Galama
Jochem M. Galama
The pathogenesis of coxsackie B virus (CVB) infections is generally studied in mice by intraperitoneal (i.p.) injection, whereas the gastrointestinal tract is the natural porte d'entrée in humans. The present study was undertaken to compare systematically the influence of infection route on morbidity and pathology. Swiss Albino mice were infected with CVB3 (Nancy) at different doses (5×103, 5×105, 5×107, 5×109 TCID50), given either i.p. or orally. Virus could be isolated from several organs (heart, spleen and pancreas), indicating systemic infection, irrespective of the infection route. Virus titres were 1–2 logs higher after i.p. infection, but kinetics were largely independent of infection route. Organs became negative for virus isolation after 21 days, with the exception of spleen tissue, which remained positive for up to 49 days. Thereafter, virus was detected only by immunohistochemistry and PCR up to 98 days post-infection (oral route). Histopathology showed mild inflammation and necrosis in heart tissue of all mice during the acute phase, with repair at later stages. Strikingly, pancreatic lesions were confined to the exocrine pancreas and observed only after i.p. infection. Under all experimental conditions, the pancreatic islets were spared. In contrast, immunohistochemistry showed the presence of viral VP1, protein 3A and alpha interferon (IFN-α) in exocrine as well as endocrine pancreas of all mice, irrespective of route and dose of infection. It is concluded that infection via the oral route protects the pancreas from damage, but not from infection, a process in which IFN-α is not the only factor involved.

10 December 2014 in Journal of Pathogens
Verified
Journal Article
Open access
PDF file
JPJana Precechtelova
Jana Precechtelova
MBMaria Borsanyiova
Maria Borsanyiova
SSSona Sarmirova
Sona Sarmirova
SBShubhada Bopegamage
Shubhada Bopegamage
We review type 1 diabetes and host genetic components, as well as epigenetics and viruses associated with type 1 diabetes, with added emphasis on the enteroviruses, which are often associated with triggering the disease. GenusEnterovirusis classified into twelve species of which seven (Enterovirus A, Enterovirus B, Enterovirus C,andEnterovirus DandRhinovirus A, Rhinovirus B,andRhinovirus C) are human pathogens. These viruses are transmitted mainly by the fecal-oral route; they may also spread via the nasopharyngeal route. Enterovirus infections are highly prevalent, but these infections are usually subclinical or cause a mild flu-like illness. However, infections caused by enteroviruses can sometimes be serious, with manifestations of meningoencephalitis, paralysis, myocarditis, and in neonates a fulminant sepsis-like syndrome. These viruses are often implicated in chronic (inflammatory) diseases as chronic myocarditis, chronic pancreatitis, and type 1 diabetes. In this review we discuss the currently suggested mechanisms involved in the viral induction of type 1 diabetes. We recapitulate current basic knowledge and definitions.

15 June 2010 in Journal of Virology
Verified
Journal Article
Closed access
MGMaria Gullberg
Maria Gullberg
CTConny Tolf
Conny Tolf
NJNina Jonsson
Nina Jonsson
CPCharlotta Polacek
Charlotta Polacek
JPJana Precechtelova
Jana Precechtelova
MLMichael Lindberg
Michael Lindberg
Coxsackievirus B2 (CVB2), one of six human pathogens of the group B coxsackieviruses within the enterovirus genus of Picornaviridae , causes a wide spectrum of human diseases ranging from mild upper respiratory illnesses to myocarditis and meningitis. The CVB2 prototype strain Ohio-1 (CVB2O) was originally isolated from a patient with summer grippe in the 1950s. Later on, CVB2O was adapted to cytolytic replication in rhabdomyosarcoma (RD) cells. Here, we present analyses of the correlation between the adaptive mutations of this RD variant and the cytolytic infection in RD cells. Using reverse genetics, we identified a single amino acid change within the exposed region of the VP1 protein (glutamine to lysine at position 164) as the determinant for the acquired cytolytic trait. Moreover, this cytolytic virus induced apoptosis, including caspase activation and DNA degradation, in RD cells. These findings contribute to our understanding of the host cell adaptation process of CVB2O and provide a valuable tool for further studies of virus-host interactions.

7 March 2016 in Virulence
Verified
Journal Article
Open access
SBShubhada Bopegamage
Shubhada Bopegamage
(2016). Enterovirus infections: Pivoting role of the adaptive immune response. Virulence: Vol. 7, No. 5, pp. 495-497.